Neurocrine Bioscience buy Cantor Fitzgerald
Start price
10.04.24
/
50%
€129.55
Target price
10.04.25
€144.01
Performance (%)
-19.76%
Price
04.10.24
€103.95
Summary
This prediction is currently active. The price of Neurocrine Bioscience has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.76%. This prediction currently runs until 10.04.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 0.873% | 0.873% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€110.65
16.09.24
16.09.24
€139.30
16.09.25
16.09.25
-6.06%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€116.40
29.08.24
29.08.24
€139.79
29.08.25
29.08.25
-10.70%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€136.10
25.07.24
25.07.24
€142.68
25.07.25
25.07.25
-23.62%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€102.55
24.10.23
24.10.23
-
24.10.24
24.10.24
-1.85%
04.10.24
04.10.24
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€126.70
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24